Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00872599 · ClinicalTrials.gov registry record · Phase 4

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

A Phase 4 study of Hypertension, sponsored by Vanderbilt University.

Completed
Registry status
Phase 4
Development phase
75
Enrollment target
1
Study location

NCT00872599 is a Phase 4 study of Hypertension that has completed, run by Vanderbilt University. The registered enrollment target is 75 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00872599, a Phase 4 study of Hypertension, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 4
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The hypothesis is to test to see if the drug fenofibrate will increase important chemicals in the body and specifically in the kidney, help to rid the body of salt by the kidneys, decrease blood pressure and improve insulin sensitivity during high-salt intake in individuals with hypertension.

Conditions Studied

Hypertension

Interventions

  • DRUG Placebo
  • DRUG fenofibrate

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2009-09
Est. Completion 2012-01
Phase Phase 4

Sponsor

Vanderbilt University

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00872599

The ClinicalTrials.gov registry entry for NCT00872599 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00872599 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00872599 about?

NCT00872599 is a clinical study titled "The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans". The hypothesis is to test to see if the drug fenofibrate will increase important chemicals in the body and specifically in the kidney, help to rid the body of salt by the kidneys, decrease blood pressure and improve insulin sensitivity during high-salt intake in individuals with hypertension.

What is the current status of trial NCT00872599?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2009-09. Estimated completion is 2012-01.

What conditions does trial NCT00872599 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00872599?

The interventions under investigation include: Placebo (DRUG), fenofibrate (DRUG).

Who is sponsoring clinical trial NCT00872599?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00872599 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.